Scientists have discovered that semaglutide, the active ingredient in drugs like Ozempic and Wegovy, offers a new benefit for the 38 million Americans with diabetes.
| # | Наименование новости | Тональность | Информативность | Дата публикации |
|---|---|---|---|---|
| 1 | Crippling Ozempic side effect threatens to shave years off the lives of millions... but, say doctors, there is a way to counteract it | 0 | 7.21 | 11-01-2026 |
| 2 | Wegovy warning: Users of weight loss jab are five times more likely to suffer permanent sight loss, finds new study | 0 | 5.2 | 11-03-2026 |
| 3 | Dr. Reddy’s to delay semaglutide supplies due to quality issue, shares hit | -2 | 6 | 09-07-2026 |
| 4 | Mental Health, Contraception Warnings Issued for Popular Weight Loss Drugs | 0 | 8.98 | 04-12-2025 |
| 5 | Weight‑loss jabs may create a new kind of yo‑yo dieting | 0 | 7 | 10-07-2026 |
| 6 | Ozempic: Hoffnung und Grenzen des Abnehmmedikaments | 0 | 7 | 07-07-2026 |
| 7 | Ученые выявили новый побочный эффект приема "Оземпика" | 0 | 7 | 30-06-2026 |
| 8 | Weight loss drugs may literally be saving people's arms and legs | 5 | 7 | 06-07-2026 |
| 9 | Novo Nordisk’s obesity drug Wegovy gets CDSCO approval to treat liver condition | 5 | 7 | 17-07-2026 |